L. Posada

Adjuvant Ipilimumab in High-Risk Uveal Melanoma

S. Patel, P. Hwu, D. Gombos, 2019, Cancers.

Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study.

S. Patel, P. Hwu, D. Gombos, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma

Merrick I Ross, James Allison, Janice N Cormier, 2018, Nature Medicine.

A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanoma

J. McQuade, R. Amaria, S. Patel, 2016, Melanoma research.

Phase II study of ipilimumab and nivolumab (ipi/nivo) in metastatic uveal melanoma (UM).

S. Patel, P. Hwu, D. Gombos, 2019, Journal of Clinical Oncology.